Cargando…
Lymphocyte to Monocyte Ratio: A New Independent Prognostic Factor in Bladder Cancer Progression?
Autores principales: | Ferro, Matteo, Caputo, Vincenzo Francesco, Barone, Biagio, Imbimbo, Ciro, de Cobelli, Ottavio, Crocetto, Felice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458796/ https://www.ncbi.nlm.nih.gov/pubmed/34568079 http://dx.doi.org/10.3389/fonc.2021.754649 |
Ejemplares similares
-
BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
por: Crocetto, Felice, et al.
Publicado: (2021) -
Lymphocyte-to-Monocyte Ratio Is the Independent Prognostic Marker of Progression in Patients Undergoing BCG-Immunotherapy for Bladder Cancer
por: Adamkiewicz, Mateusz, et al.
Publicado: (2021) -
A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer
por: Crocetto, Felice, et al.
Publicado: (2022) -
Kaempferol, Myricetin and Fisetin in Prostate and Bladder Cancer: A Systematic Review of the Literature
por: Crocetto, Felice, et al.
Publicado: (2021) -
Prognostic value of lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio in follicular lymphoma: a retrospective cohort study
por: Lee, Shing Fung, et al.
Publicado: (2017)